Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Did you buy these stocks last year? - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Dec 30, 2010

    Did you buy these stocks last year?

    After witnessing one of the sharpest rises in 2009, stocks markets in India had a strong outing in 2010 as well. While the BSE-Sensex rose by 15% YoY, the BSE-100 Index rose by 13% YoY (closing quotes for both the indices as on 28 Dec 2010). In 2009, the two indices surged by a sharp 81% YoY and 85% YoY respectively.

    In this article, we will be discussing the best performing stocks in 2010 forming part of the BSE-100 Index. The list goes as follows - Bank of Baroda (banking), Bajaj Auto (auto), Sun Pharmaceuticals (healthcare), Tata Motors (auto) and Shriram Transport Finance Co. Ltd (NBFC).

    Bank of Baroda (Returns in 2010 - 74%; 2009 - 82%)

    Bank of Baroda's ascent in terms of valuations during 2010 were primarily driven by two factors. One that the bank's valuations were brought at par to that of its PSU peers with similar fundamentals and growth prospects. Two, despite being a PSU, Bank of Baroda did not bear the brunt of restructured assets on its asset quality like its peers. In addition improvement in margins also helped the bank improve profitability expectations. Efforts on the fee income front and plans of hiring around 4,200 employees for the additional franchises during the next fiscal gave investors some visibility about the bank's revenue growth prospects.

    Data Source: CMIE Prowess

    Bajaj Auto (Returns in 2010 - 68%; 2009- 350%) and Tata Motors (Returns in 2010- 61%; 2009 - 398%)

    Auto stocks continued their strong performance in 2010. In 2009, stocks of Bajaj Auto and Tata Motors rose by a massive 350% YoY and 398% YoY respectively. These stocks were part of the top performers list in 2009 as well.

    In 2010, they continued to perform well on the back of the strong increase in volumes. Bajaj Auto, for instance, reported a strong 56% YoY increase in volumes sales during 1HFY11. Volumes in the months thereafter have remained strong as well. While the company does not have a very vast product portfolio, this very fact played a good role in the volumes boost. The company's renewed interest in the entry level segment (in the form of the 'Discover' brand) helped it gain strong market over the last year. Apart from the good volumes, the company also put up a very good operating performance as it was able to maintain margins close to the previous year levels. This is at a time when the industry is witnessing pressure at the operating level on the back of higher input costs.

    As for Tata Motors, while the company benefitted from the continued offtake in sales of commercial vehicles, the stock got a boost on the back of the bounce back in sales of its subsidiaries - Jaguar and Land Rover (JLR). Wholesale sales volumes for these two entities increased by 27% YoY and 42% YoY respectively. As for the company's financial performance, there is a stark difference as compared to last year. While consolidated revenues rose by 49% YoY during 1HFY11, its operating profits surged by 291% YoY. This was on the back of a strong performance of JLR. In fact, JLR's profitability was better than that of the standalone entity during this period.

    Data Source: CMIE Prowess

    Sun Pharmaceuticals (Returns in 2010 - 59%; 2009 - 42%)

    The stock of Sun Pharma derived the benefit of good performance during 1HFY11 with impressive growth in sales and profits. Having said that, this performance was largely attributed to the one-time sales that the company generated from the cancer drug 'Eloxatin', which was distributed by Caraco in the US market. Due to a court order which banned Sun Pharma from selling the drug, there were no revenues from the same in the second quarter. The company was up against Sanofi-Aventis SA, which had appealed for barring Sun Pharma to market the generic version of the drug in the US. However, recently, a US appeals court ruled a case in favour of Sun Pharma with respect to this drug which could be one of the reasons for the interest in the stock.

    The second major development that took place for Sun Pharma this year was related to the Israeli firm Taro. The uncertainty surrounding the acquisition of this company came to an end when the Israeli Supreme Court ruled in Sun Pharma's favour. Now with Taro's financials being clubbed with that of Sun Pharma's, the latter's sales are expected to ramp up during FY11.

    Data Source: CMIE Prowess

    Shriram Transport Finance (Returns in 2010- 59%; 2009 - 149%)

    Shriram Transport Finance had a stellar 2010. It has an impressive run in the stock markets, running up by about 59% YoY. The company has a stronghold over the entire used truck manufacturing business with an over 70% share. Well, with the entire auto sector staging a comeback, the auto financers were not to be left behind. Even with the RBI hiking rates 6 times this year, disbursements managed to grow at 25%. New commercial vehicles also saw a push with general buoyancy in the rural markets due to a good monsoon and higher employment. A 31% increase in disbursements of new-commercial vehicles was seen. This business however has lower yields compared to financing older vehicles.

    The current quarter (3QFY11) should also be good for the company due to increased buying in the festival season. The company also started Shriram Automall, a platform for second hand truck trading this year. Its equipment financing division was also launched, which is expected to benefit from the US$ 1 trillion infrastructure investment expected in the 12th five-year plan.

    Data Source: CMIE Prowess


    With the BSE-Sensex and the BSE-100 indices ending the year on a strong note, many largecap stocks have reached valuations that are above our comfort levels. While some may believe that these valuations are justified on the back of higher earnings expectations, investors should keep in mind that FY10 was a year where most of the companies reported strong operating performances. This was both in terms of a margin expansion as well as strong earnings growth. However, it is only a matter of time before the base effect kicks in and a normalised growth rates come into play. On the same occurring, the high valuations will not seem justified.

    Therefore, if you missed out on the winners of 2010 and are looking at making up for it in 2011, make sure that you have a closer look at the valuations before investing.

    Happy stock picking in 2011!



    Equitymaster requests your view! Post a comment on "Did you buy these stocks last year?". Click here!

    13 Responses to "Did you buy these stocks last year?"

    chitra nathwani

    Jan 20, 2011

    better expertise expected



    Jan 12, 2011

    i feel that this is a method of cheating people and making noney..



    Jan 12, 2011

    some of the recommendations have worked, but most have not. need to hit the nail on the head many more times. look forward to more accurate buy/sell forecasts.


    P. Srinivasan

    Jan 11, 2011

    Anybody can make this report with the data available publicly. The use of hindsight by all investors in stock market is continous and the feeling :" If I had done that..". So what is the use of spending time to write articles which almost all investors keep muttering day in and day out, bull or bear market?

    End game is: We are not making money, long term,medium term or short term. Period.



    Jan 9, 2011

    You are suppossed to be experts. Such articles are like a news bulletin.



    Jan 8, 2011




    Jan 8, 2011

    I think if we make sure we sell stocks which equitymaster recommends or go short on those stocks, we will make lot of money :-)
    One or 2 stocks recommended by them do good while most of them do not.



    Jan 8, 2011

    Do you think your recommendations are worth for paying or
    total wastage of money. Give your opinion. we will reply.



    Jan 8, 2011

    I have no purchsed



    Jan 7, 2011

    There are over 5000 sensex active share, what is the use of telling whathappened in 2010. I am subscribed to midcap select, stock select and am yet to find something really outperforming in the recent past. Share selection need a lot analysis, in sight, and careful planning, what is already known to public will be of no use

    Equitymaster requests your view! Post a comment on "Did you buy these stocks last year?". Click here!

    More Views on News

    How to Ride Alongside India's Best Fund Managers (The 5 Minute Wrapup)

    Jun 10, 2017

    Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.

    You've Heard of Timeless Books... Ever Heard of Timeless Stocks? (The 5 Minute Wrapup)

    Aug 19, 2017

    Ever heard of Lindy Effect? Find out how you can use it to pick timeless stocks.

    Why NOW Is the WORST Time for Index Investing (The 5 Minute Wrapup)

    Aug 18, 2017

    Buying the index now will hardly help make money in stocks even in ten years.

    Trump Takes a Beating (Vivek Kaul's Diary)

    Aug 18, 2017

    Donald J Trump, a wrasslin' fan, took a 'Holy Sh*t!' blow on Tuesday.

    How To Read Your Mutual Fund Account Statement Correctly (Outside View)

    Aug 17, 2017

    PersonalFN simplifies the mutual fund account statement for you.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 18, 2017 (Close)